Literature DB >> 3624484

Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.

R A Eisenberg, S Y Craven, R W Warren, P L Cohen.   

Abstract

MRL/Mp-lpr/lpr autoimmune mice consistently show an approximately 25% incidence of the systemic lupus erythematosus marker autoantibody anti-Sm. In the present report, we show that the failure to find anti-Sm antibodies in three-quarters of 5-mo-old MRL/lpr mice was not an artifact of an insensitive assay, but rather that the mice fell into two populations as regards their anti-Sm positivity. Based on an extensive analysis of the incidence of anti-Sm positivity in 5-mo-old mice according to their cage of residence, we found no evidence for genetic, environmental, or parental influences on the propensity of an individual animal to become anti-Sm positive. Also, the gender of the mouse, its Sm antigen level, or its length of survival were not related to anti-Sm antibody, nor was the anti-Sm antibody status of either parent. Some animals became anti-Sm positive after 5 mo of age, but this was less likely than becoming positive before 5 mo of age. Finally, a survey of 205 autoimmune C57BL/6-lpr/lpr mice confirmed the uniqueness of the MRL background for this autoantibody response. These results together indicate that the possibility of making anti-Sm antibodies is under genetic control, but that the expression of this capability in an individual animal is governed by stochastic events. We hypothesize further that such random processes may involve the expression of particular immunoglobulin variable-region genes combined with mechanisms of extensive somatic mutation or positive feedback amplification, which would transmute an initial monoclonal response into an eventual polyclonal one.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624484      PMCID: PMC442292          DOI: 10.1172/JCI113123

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Profiles of antinuclear antibodies in systemic rheumatic diseases.

Authors:  D D Notman; N Kurata; E M Tan
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction.

Authors:  J B Winfield; C M Brunner; D Koffler
Journal:  Arthritis Rheum       Date:  1978-04

3.  The polypeptide structure of the Sm and RNP nuclear antigens.

Authors:  R A Eisenberg; D G Klapper; P L Cohen
Journal:  Mol Immunol       Date:  1983-02       Impact factor: 4.407

Review 4.  The generation of diversity in phosphorylcholine-binding antibodies.

Authors:  R M Perlmutter; S T Crews; R Douglas; G Sorensen; N Johnson; N Nivera; P J Gearhart; L Hood
Journal:  Adv Immunol       Date:  1984       Impact factor: 3.543

5.  Antibodies to Sm and RNP. Prognosticators of disease involvement.

Authors:  E F Munves; P H Schur
Journal:  Arthritis Rheum       Date:  1983-07

6.  Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

Authors:  E M Tan; H G Kunkel
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

7.  The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies.

Authors:  I Pettersson; M Hinterberger; T Mimori; E Gottlieb; J A Steitz
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

8.  Specificities of antinuclear antibodies detected in dogs with systemic lupus erythematosus.

Authors:  O Costa; C Fournel; E Lotchouang; J C Monier; M Fontaine
Journal:  Vet Immunol Immunopathol       Date:  1984-10       Impact factor: 2.046

9.  Immunologic observations on 9 sets of twins either concordant or discordant for SLE.

Authors:  S R Block; M D Lockshin; J B Winfield; M E Weksler; M Imamura; R J Winchester; R C Mellors; C L Christian
Journal:  Arthritis Rheum       Date:  1976 May-Jun

10.  Presence of anti-Sm reactivity in autoimmune mouse strains.

Authors:  R A Eisenberg; E M Tan; F J Dixon
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity.

Authors:  R A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  1992

2.  A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis.

Authors:  Sarah Bradshaw; W Jim Zheng; Lam C Tsoi; Gary Gilkeson; Xian K Zhang
Journal:  Clin Immunol       Date:  2008-08-09       Impact factor: 3.969

3.  Regulation of the anti-Sm autoantibody response in systemic lupus erythematosus mice by monoclonal anti-Sm antibodies.

Authors:  R A Eisenberg; D S Pisetsky; S Y Craven; J P Grudier; M A O'Donnell; P L Cohen
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

Review 4.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

5.  Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression.

Authors:  J J Letterio; A G Geiser; A B Kulkarni; H Dang; L Kong; T Nakabayashi; C L Mackall; R E Gress; A B Roberts
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus.

Authors:  Vaidehi R Chowdhary; Chao Dai; Ashenafi Y Tilahun; Julie A Hanson; Michele K Smart; Joseph P Grande; Govindarajan Rajagopalan; Shu-Man Fu; Chella S David
Journal:  J Immunol       Date:  2015-10-16       Impact factor: 5.422

7.  Roles of interferon-gamma and interleukin-4 in murine lupus.

Authors:  S L Peng; J Moslehi; J Craft
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 8.  Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases.

Authors:  Antony Rosen; Livia Casciola-Rosen
Journal:  Annu Rev Immunol       Date:  2016-02-22       Impact factor: 28.527

9.  Immunization with the Sm nuclear antigen induces anti-Sm antibodies in normal and MRL mice.

Authors:  E W Shores; D S Pisetsky; J Grudier; R A Eisenberg; P L Cohen
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

Review 10.  Mechanisms of autoimmunity.

Authors:  Robert Eisenberg
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.